| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |